Table of Content

1 INTRODUCTION 
    1.1 OBJECTIVES OF THE STUDY 
    1.2 MARKET DEFINITION 
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY 
    1.5 STAKEHOLDERS 
    1.6 SUMMARY OF CHANGES 
    1.7 RECESSION IMPACT 
2 RESEARCH METHODOLOGY 
    2.1 RESEARCH DATA 
    2.2 RESEARCH APPROACH 
    2.3 RESEARCH METHODOLOGY DESIGN 
    2.4 MARKET SIZE ESTIMATION 
    2.5 MARKET BREAKDOWN AND DATA TRIANGULATION 
    2.6 RESEARCH ASSUMPTIONS  
    2.7 RISK ASSESSMENT 
    2.8 RESEARCH LIMITATIONS 
           2.8.1 METHODOLOGY-RELATED LIMITATIONS 
           2.8.2 SCOPE-RELATED LIMITATIONS 
    2.9 RECESSION IMPACT 
3 EXECUTIVE SUMMARY 
4 PREMIUM INSIGHTS 
5 MARKET OVERVIEW 
    5.1 MARKET DYNAMICS  
           5.1.1 DRIVERS 
           5.1.2 RESTRAINTS 
           5.1.3 OPPORTUNITIES 
           5.1.4 CHALLENGES 
    5.2 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
    5.3 INDUSTRY TRENDS 
    5.4 ECOSYSTEM ANALYSIS 
    5.5 VALUE CHAIN ANALYSIS 
    5.6 TECHNOLOGY ANALYSIS  
    5.7 TARIFF AND REGULATORY LANDSCAPE  
           5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 
           5.7.2 REGULATORY ANALYSIS 
                    5.7.2.1 North America 
                               5.7.2.1.1 US 
                               5.7.2.1.2 Canada 
                    5.7.2.2 Europe 
                    5.7.2.3 Asia Pacific 
                               5.7.2.3.1 Japan 
                               5.7.2.3.2 China 
                               5.7.2.3.3 India 
                    5.7.2.4 Latin America 
    5.8 PRICING ANALYSIS 
           5.8.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY SOFTWARE
           5.8.2 AVERAGE SELLING PRICE TREND, BY REGION 
    5.9 PORTER’S FIVE FORCES ANALYSIS 
    5.10 PATENT ANALYSIS 
    5.11 KEY STAKEHOLDERS AND BUYING CRITERIA  
           5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS 
           5.11.2 BUYING CRITERIA 
    5.12 END USER ANALYSIS 
           5.12.1 UNMET NEEDS
           5.12.2 END USER EXPECTATIONS 
    5.13 KEY CONFERENCES & EVENTS IN 2023-2024 
    5.14 RADIATION DOSE MANAGEMENT INVESTMENT LANDSCAPE 
    5.15 RADIATION DOSE MANAGEMENT BUSINESS MODELS 
    5.16 USE CASES/CASE STUDIES 
6 RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE 
    6.1 INTRODUCTION 
    6.2 RADIATION DOSE MANAGEMENT SOLUTIONS 
           6.2.1 STANDALONE SOLUTIONS
           6.2.2 INTEGRATED SOLUTIONS
    6.3 RADIATION DOSE MANAGEMENT SERVICES 
           6.3.1 SUPPORT & MAINTENANCE SERVICES
           6.3.2 IMPLEMENTATION & INTERATION SERVICES 
           6.3.3 CONSULTING SERVICES
           6.3.4 EDUCATION & TRAINING SERVICES
7 RADIATION DOSE MANAGEMENT MARKET, BY MODALITY 
    7.1 INTRODUCTION  
    7.2 COMPUTED TOMOGRAPHY 
    7.3 FLUOROSCOPY & INTERVENTIONAL IMAGING 
    7.4 RADIOLOGY  
    7.5 MAMMOGRAPHY 
    7.6 NUCLEAR MEDICINE 
8 RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT 
    8.1 INTRODUCTION 
    8.2 ON-PREMISE  
    8.3 CLOUD-BASED  
    8.4 WEB-BASED 
9 RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL 
    9.1 CAPITAL/ANNUAL PURCHASE MODEL 
    9.2 PAY-PER PROCEDURE MODEL 
    9.3 OTHERS (IF ANY) 
10 RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION 
     10.1 INTRODUCTION 
     10.2 ONCOLOGY 
     10.3 CARDIOLOGY 
     10.4 DENTAL 
     10.5 ORTHOPEDIC APPLICATIONS 
     10.6 OTHER APPLICATION (NEUROIMAGING, GENITOURINARY IMAGING, ETC) 
11 RADIATION DOSE MANAGEMENT MARKET, BY ENDUSER 
     11.1 INTRODUCTION 
     11.2 HOSPITALS AND HEALTHCARE SYSTEM 
     11.3 AMBULATORY SURGERY CENTER 
     11.3 DIAGNOSTIC AND IMAGING CENTER 
     11.4 OTHER END USERS (ACADEMIC RESEARCH INSTITUTION, PUBLIC AND PRIVATE RESEARCH LABORATORIES) 
12 RADIATION DOSE MANAGEMENT MARKET, BY REGION  
     12.1 INTRODUCTION  
     12.2 NORTH AMERICA  
             12.2.1 US 
             12.2.2 CANADA 
             12.2.3 NORTH AMERICA: IMPACT OF ECONOMIC RECESSION
     12.3 EUROPE  
             12.3.1 GERMANY 
             12.3.2 FRANCE 
             12.3.3 UK 
             12.3.4 ITALY 
             12.3.5 SPAIN 
             12.3.6 REST OF EUROPE 
             12.3.7 EUROPE: IMPACT OF ECONOMIC RECESSION
     12.4 ASIA PACIFIC  
             12.4.1 CHINA 
             12.4.2 JAPAN 
             12.4.3 INDIA 
             12.4.3 REST OF ASIA PACIFIC
             12.4.5 ASIA PACIFIC: IMPACT OF ECONOMIC RECESSION
     12.5 LATIN AMERICA  
             12.5.1 BRAZIL
             12.5.2 MEXICO
             12.5.3 REST OF LATIN AMERICA
             12.5.4 LATIN AMERICA: IMPACT OF ECONOMIC RECESSION
     12.6 MIDDLE EAST AND AFRICA  
             12.6.1 GCC COUNTRIES
             12.6.2 REST OF MIDDLE EAST & AFRICA
             12.6.3 MIDDLE EAST & AFRICA: IMPACT OF ECONOMIC RECESSION
13 COMPETITIVE LANDSCAPE  
     13.1 OVERVIEW  
     13.2 STRATEGIES ADOPTED BY KEY PLAYERS  
     13.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS  
     13.4 MARKET SHARE/RANKING ANALYSIS  
     13.5 BRAND/SOFTWARE COMPARATIVE ANALYSIS 
     13.6 VALUATION AND FINANCIAL METRICS OF KEY RADIATION DOSE MANAGEMENT VENDORS 
     13.7 COMPANY EVALUATION MATRIX 
             13.7.1 STARS 
             13.7.2 EMERGING LEADERS 
             13.7.3 PERVASIVE PLAYERS 
             13.7.4 PARTICIPANTS 
             13.7.5 COMPANY FOOTPRINT
     13.8 START- UP/SME EVALUATION MATRIX 
             13.8.1 PROGRESSIVE COMPANIES 
             13.8.2 RESPONSIVE COMPANIES 
             13.8.3 DYNAMIC COMPANIES
             13.8.4 STARTING BLOCKS
             13.8.5 COMPETITIVE BENCHMARKING
     13.9 COMPETITIVE SCENARIO AND TRENDS 
             13.9.1 PRODUCT LAUNCHES
             13.9.2 DEALS
             13.9.3 OTHERS
14 COMPANY PROFILES 
     14.1 KEY PLAYERS 
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) *
             14.1.1 BAYER AG
             14.1.2 GE HEALTHCARE
             14.1.3 PHILIPS HEALTHCARE
             14.1.4 SECTRA AB
             14.1.5 AGFA HEALTHCARE
             14.1.6 SIEMENS HEALTHCARE
             14.1.7 FUJIFILM HOLDINGS CORPORATION
             14.1.8 CANON, INC.
             14.1.9 GUERBET
             14.1.10 PACSHEALTH
             14.1.11 NOVARAD CORPORATION
             14.1.12 QAELUM
             14.1.13 BRACCO
             14.1.14 INFINITT HEALTHCARE
             14.1.15 MEDSQUARE SAS
     14.2 OTHER KEY PLAYERS 
             14.2.1 VOLPARA HEALTH LIMITED.
             14.2.2 MEDIC VISION
             14.2.3 IMALOGIX.
             14.2.4 DEDALUS S.P.A.
             14.2.5 NANJING PERLOVE MEDICAL EQUIPMENT CO., LTD.
             14.2.6 MIRION TECHNOLOGIES, INC. 
             14.2.7 LANDAUER
             14.2.8 CENTRONIC
             14.2.9 POLIMASTER
             14.2.10 FORTIVE
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
15 APPENDIX 
     15.1 DISCUSSION GUIDE 
     15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     15.3 AVAILABLE CUSTOMIZATIONS 
     15.4 RELATED REPORTS 
     15.5 AUTHOR DETAILS